Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ainos Inc. (AIMD:NASDAQ), powered by AI.
Ainos Inc. is currently trading at $3.16. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Ainos Inc. on Alpha Lenz.
Ainos Inc.'s P/E ratio is -0.9.
“Ainos Inc. trades at a P/E of -0.9 (undervalued) with modest ROE of -128.0%.”
Ask for details →Ainos Inc. is a biotech and healthcare technology company primarily focused on the development and commercialization of innovative diagnostic and therapeutic solutions. Ainos offers a portfolio of products and services that address critical unmet medical needs, particularly in the areas of infectious diseases and chronic health conditions. The company's technological advancements include proprietary biosensor technologies and smart medical devices, which pave the way for more precise, rapid, and cost-effective health diagnostics. Ainos Inc.'s activities impact several sectors, such as healthcare, biotechnology, and medical devices, by introducing breakthrough approaches that enhance patient care and enable early disease detection. By doing so, the company contributes to the improvement of public health and the efficiency of healthcare systems. Operating in rapidly evolving markets, Ainos is strategically positioned to influence future trends in personalized medicine and connected health solutions. The firm's commitment to innovation and cutting-edge technology underscores its role in advancing healthcare diagnostics and therapeutics in a competitive global market.
“Ainos Inc. trades at a P/E of -0.9 (undervalued) with modest ROE of -128.0%.”
Ask for details →Ainos Inc. (ticker: AIMD) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 44 employees. Market cap is $13M.
The current price is $3.16 with a P/E ratio of -0.91x and P/B of 1.78x.
ROE is -128.00% and operating margin is -11268.32%. Annual revenue is $124,157.